|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Carr SR, Akerley W and Cannon-Albright LA:
Genetic contribution to nonsquamous, non-small cell lung cancer in
nonsmokers. J Thorac Oncol. 13:938–945. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Greathouse KL, White JR, Vargas AJ,
Bliskovsky VV, Beck JA, von Muhlinen N, Polley EC, Bowman ED, Khan
MA, Robles AI, et al: Interaction between the microbiome and TP53
in human lung cancer. Genome Biol. 19:1232018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Velcheti V, Madison R, Ali SM and Schrock
AB: WAC/RET: A novel RET oncogenic fusion variant in non-small cell
lung carcinoma. J Thorac Oncol. 13:e122–e123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tsui DWY, Murtaza M, Wong ASC, Rueda OM,
Smith CG, Chandrananda D, Soo RA, Lim HL, Goh BC, Caldas C, et al:
Dynamics of multiple resistance mechanisms in plasma DNA during
EGFR-targeted therapies in non-small cell lung cancer. EMBO Mol
Med. 10:e79452018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Li S, Yang J, Xia Y, Fan Q and Yang KP:
Long noncoding RNA NEAT1 promotes proliferation and invasion via
targeting miR-181a-5p in non-small cell lung cancer. Oncol Res.
26:289–296. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Thomas A, Rajan A, Lopez-Chavez A, Wang Y
and Giaccone G: From targets to targeted therapies and molecular
profiling in non-small cell lung carcinoma. Ann Oncol. 24:577–585.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Vijayvergia N, Shah PC and Denlinger CS:
Survivorship in non-small cell lung cancer: Challenges faced and
steps forward. J Natl Compr Canc Netw. 13:1151–1161. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kudo Y, Haymaker C, Zhang J, Reuben A,
Duose DY, Fujimoto J, Roy-Chowdhuri S, Solis Soto LM, Dejima H,
Parra ER, et al: Suppressed immune microenvironment and repertoire
in brain metastases from patients with resected non-small-cell lung
cancer. Ann Oncol. 30:1521–1530. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang Y, Cao G, Zhao G, Wang C and Qin Q:
LncRNA differentiation antagonizing non-protein coding RNA promotes
proliferation and invasion through regulating miR-135a/NLRP37 axis
in pancreatic cancer. Invest New Drugs. 38:714–721. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Chen LL: Linking Long noncoding RNA
localization and function. Trends Biochem Sci. 41:761–772. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
St Laurent G, Wahlestedt C and Kapranov P:
The Landscape of long noncoding RNA classification. Trends Genet.
31:239–251. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kopp F and Mendell JT: Functional
classification and experimental dissection of long noncoding RNAs.
Cell. 172:393–407. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Jin J, Wang H, Si J, Ni R, Liu Y and Wang
J: ZEB1-AS1 is associated with poor prognosis in non-small-cell
lung cancer and influences cell migration and apoptosis by
repressing ID1. Clin Sci (Lond). 133:381–392. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Yang H, Yan L, Sun K, Sun X, Zhang X, Cai
K and Song T: lncRNA BCAR4 increases viability, invasion, and
migration of non-small cell lung cancer cells by targeting
glioma-associated oncogene 2 (GLI2). Oncol Res. 27:359–369.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shi SL and Zhang ZH: Long non-coding RNA
SNHG1 contributes to cisplatin resistance in non-small cell lung
cancer by regulating miR-140-5p/Wnt/β-catenin pathway. Neoplasma.
66:756–765. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kamel LM, Atef DM, Mackawy AMH, Shalaby SM
and Abdelraheim N: Circulating long non-coding RNA GAS5 and SOX2OT
as potential biomarkers for diagnosis and prognosis of non-small
cell lung cancer. Biotechnol Appl Biochem. 66:634–642. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou Y, Shi H, Du Y, Zhao G, Wang X, Li Q,
Liu J, Ye L, Shen Z, Guo Y and Huang Y: lncRNA DLEU2 modulates cell
proliferation and invasion of non-small cell lung cancer by
regulating miR-30c-5p/SOX9 axis. Aging (Albany NY). 11:7386–7401.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Xu Y, Zheng Y, Liu H and Li T: Modulation
of IGF2BP1 by long non-coding RNA HCG11 suppresses apoptosis of
hepatocellular carcinoma cells via MAPK signaling transduction. Int
J Oncol. 51:791–800. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Liu H, Li J, Koirala P, Ding X, Chen B,
Wang Y, Wang Z, Wang C, Zhang X and Mo YY: Long non-coding RNAs as
prognostic markers in human breast cancer. Oncotarget.
7:20584–20596. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Y, Zhang P, Wan X, Su X, Kong Z,
Zhai Q, Xiang X, Li L and Li Y: Downregulation of long non-coding
RNA HCG11 predicts a poor prognosis in prostate cancer. Biomed
Pharmacother. 83:936–941. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Costa GJ, Mello MJG, Bergmann A, Ferreira
CG and Thuler LCS: Tumor-node-metastasis staging and treatment
patterns of 73,167 patients with lung cancer in Brazil. J Bras
Pneumol. 46:e201802512020.(In English, Portuguese). View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Roy SK, Shrivastava A, Srivastav S,
Shankar S and Srivastava RK: SATB2 is a novel biomarker and
therapeutic target for cancer. J Cell Mol Med. 24:11064–11069.
2020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Jemal A, Siegel R, Xu J and Ward E: Cancer
statistics, 2010. CA Cancer J Clin. 60:277–300. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van Rens MT, Zanen P, Brutel de La Riviere
A, Elbers HR, van Swieten HA and van Den Bosch JM: Survival in
synchronous vs. single lung cancer: upstaging better reflects
prognosis. Chest. 118:952–958. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Marcus MW, Raji OY and Field JK: Lung
cancer screening: Identifying the high risk cohort. J Thorac Dis. 7
(Suppl 2):S156–S162. 2015.PubMed/NCBI
|
|
27
|
Li Y, Li L, Wang Z, Pan T, Sahni N, Jin X,
Wang G, Li J, Zheng X, Zhang Y, et al: LncMAP: Pan-cancer atlas of
long noncoding RNA-mediated transcriptional network perturbations.
Nucleic Acids Res. 46:1113–1123. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Zhang E, He X, Zhang C, Su J, Lu X, Si X,
Chen J, Yin D, Han L and De W: A novel long noncoding RNA HOXC-AS3
mediates tumorigenesis of gastric cancer by binding to YBX1. Genome
Biol. 19:1542018. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Khan MR, Xiang S, Song Z and Wu M: The
p53-inducible long noncoding RNA TRINGS protects cancer cells from
necrosis under glucose starvation. EMBO J. 36:3483–3500. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Yang F, Bi J, Xue X, Zheng L, Zhi K, Hua J
and Fang G: Up-regulated long non-coding RNA H19 contributes to
proliferation of gastric cancer cells. FEBS J. 279:3159–3165. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Cao S, Liu W, Li F, Zhao W and Qin C:
Decreased expression of lncRNA GAS5 predicts a poor prognosis in
cervical cancer. Int J Clin Exp Pathol. 7:6776–6783.
2014.PubMed/NCBI
|
|
32
|
Chen Y, Bao C, Zhang X, Lin X, Huang H and
Wang Z: Long non-coding RNA HCG11 modulates glioma progression
through cooperating with miR-496/CPEB3 axis. Cell Prolif.
52:e126152019. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wang YC, He WY, Dong CH, Pei L and Ma YL:
lncRNA HCG11 regulates cell progression by targeting miR-543 and
regulating AKT/mTOR pathway in prostate cancer. Cell Biol Int. Nun
22–2019.(Epub ahead of print). doi: 10.1002/cbin.11194. View Article : Google Scholar
|
|
34
|
Cramer JD, Burtness B, Le QT and Ferris
RL: The changing therapeutic landscape of head and neck cancer. Nat
Rev Clin Oncol. 16:669–683. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Evans ER, Bugga P, Asthana V and Drezek R:
Metallic Nanoparticles for Cancer Immunotherapy. Mater Today
(Kidlington). 21:673–685. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Turajlic S, Sottoriva A, Graham T and
Swanton C: Resolving genetic heterogeneity in cancer. Nat Rev
Genet. 20:404–416. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Long R, Liu Z, Li J, Zhang Y and Yu H:
HCG11 up-regulation induced by ELK4 suppressed proliferation in
vestibular schwannoma by targeting miR-620/ELK4. Cancer Cell Int.
21:52021. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Li XF, Hu DM, Zhao YX, Zhang L and Jin Y:
Knockdown of lncRNA HCG11 suppresses cell progression in ovarian
cancer by modulating miR-144-3p/PBX3. Eur Rev Med Pharmacol Sci.
24:11032–11040. 2020.PubMed/NCBI
|
|
39
|
Tong JL, Wang LL, Ling XF, Wang MX, Cao W
and Liu YY: MiR-875 can regulate the proliferation and apoptosis of
non-small cell lung cancer cells via targeting SOCS2. Eur Rev Med
Pharmacol Sci. 23:5235–5241. 2019.PubMed/NCBI
|
|
40
|
Liang C, Liu H, Hao J, Li J and Luo L:
Expression profiling and regulatory network of cucumber microRNAs
and their putative target genes in response to cucumber green
mottle mosaic virus infection. Arch Virol. 164:1121–1134. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Li J, Huang L, Xiao X, Chen Y, Wang X,
Zhou Z, Zhang C and Zhang Y: Photoclickable microRNA for the
intracellular target identification of microRNAs. J Am Chem Soc.
138:15943–15949. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Wang Y, Luo J, Zhang H and Lu J: microRNAs
in the same clusters evolve to coordinately regulate functionally
related genes. Mol Biol Evol. 33:2232–2247. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Kucuksayan H, Ozes ON and Akca H:
Downregulation of SATB2 is critical for induction of
epithelial-to-mesenchymal transition and invasion of NSCLC cells.
Lung Cancer. 98:122–129. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tian W, Wang G, Liu Y, Huang Z, Zhang C,
Ning K, Yu C, Shen Y, Wang M, Li Y, et al: The miR-599 promotes
non-small cell lung cancer cell invasion via SATB2. Biochem Biophys
Res Commun. 485:35–40. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Ma YN, Zhang HY, Fei LR, Zhang MY, Wang
CC, Luo Y and Han YC: SATB2 suppresses non-small cell lung cancer
invasiveness by G9a. Clin Exp Med. 18:37–44. 2018. View Article : Google Scholar : PubMed/NCBI
|
